Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

Bacterial reverse mutation test:

An in vitro gene mutation study in bacteria according to OECD 471 and GLP with the registered substance (CAS 93-08-3) is ongoing. Test results will be submitted after receiving the final study report.

In vitro mammalian cell chromosome aberration test:

An in vitro cytogenicity study according to OECD 473 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.

In vitro gene mutation test in mammalian cell:

An in vitro gene mutation study in mammalian cells according to OECD 476 and GLP with the registered substance (CAS 93-08-3) is ongoing.Test results will be submitted after receiving the final study report.

 

Link to relevant study records

Referenceopen allclose all

Endpoint:
in vitro gene mutation study in bacteria
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint:
in vitro gene mutation study in mammalian cells
Data waiving:
other justification
Justification for data waiving:
other:
Justification for type of information:
This information will be submitted later based on the ECHA communication number CCH-D-2114501340-71-01/F.
Endpoint conclusion
Endpoint conclusion:
no study available

Genetic toxicity in vivo

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

Justification for classification or non-classification

In vitro gene mutation studies in bacterial and mammalian cells according to OECD 471 and OECD 476 are ongoing with the registered substance (CAS 93-08-3). Also, an in vitro cytogenicity study according to OECD 473 with the registered substance (CAS 93-08-3) is running. Hence, justification for classification or non-classification will be added upon receiveng these test results.